Excitotoxic potential of the cyanotoxin β-methyl-amino-l-alanine (BMAA) in primary human neurons
Authors:
- Michelle M. GehringerMichelle M. Gehringer
- Nady BraidyNady Braidy
- Gilles J. GuilleminGilles J. Guillemin
- Jeffrey H. WelchJWJeffrey H. Welch
- Brett A. NeilanBrett A. Neilan
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council
- University of New South Wales
- Association pour la Recherche sur la Sclérose amyotrophique latérale (ARS)
This publication has 36 references indexed in Scilit:
- Transfer of a cyanobacterial neurotoxin within a temperate aquatic ecosystem suggests pathways for human exposureProceedings of the National Academy of Sciences, 2010
- Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s diseaseActa Neurologica Scandinavica, 2009
- Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivoNeuroToxicology, 2007
- BMAA selectively injures motor neurons via AMPA/kainate receptor activationExperimental Neurology, 2006
- NMDA receptor regulation of nNOS phosphorylation and induction of neuron deathNeurobiology of Aging, 2003
- Distribution of the neurotoxic nonprotein amino acid BMAA in Cycas micronesicaBotanical Journal of the Linnean Society, 2003
- Interaction between ß-N-methylamino- l-alanine and excitatory amino acid receptors in brain slices and neuronal culturesBrain Research, 1991
- Glutamate neurotoxicity and diseases of the nervous systemNeuron, 1988
- CYCAD USE AND MOTOR NEURONE DISEASE IN KII PENINSULA OF JAPANThe Lancet, 1987
- CYCAD USE AND MOTOR NEURONE DISEASE IN IRIAN JAYAThe Lancet, 1987